Inotropic support during experimental endotoxemic shock: Part I. the effects of levosimendan on splanchnic perfusion

Anesthesia and Analgesia

Volumn 109, Issue 5, 2009, Pages 1568-1575

  Cunha Goncalves, Doris ^a   Perez De Sa, Valeria ^a   Grins, Edgars ^a   Dahm, Peter L ^b   Thörne, Johan ^c   Blomquist, Sten ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Ystad Hospital   (Sweden)

^c HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN 70; ENDOTOXIN; INFUSION FLUID; LEVOSIMENDAN; OXYGEN; PLACEBO; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; LACTIC ACID; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, ESCHERICHIA COLI 0111 B4; PYRIDAZINE DERIVATIVE; SIMENDAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOWMETRY; BLOOD SAMPLING; CANNULATION; CAROTID ARTERY; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFECT; ENDOTOXEMIA; FLUID RESUSCITATION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HEPATIC VEIN; INOTROPISM; INTESTINE BLOOD FLOW; JUGULAR VEIN; LIVER BLOOD FLOW; LIVER PERFUSION; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NONHUMAN; OXYGEN CONSUMPTION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION PRESSURE; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY; SWINE; SYSTEMIC CIRCULATION; SYSTEMIC VASCULAR RESISTANCE; THERMODILUTION; ANIMAL; BLOOD; BLOOD FLOW; BLOOD PRESSURE; BLOOD VOLUME; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FLUID THERAPY; HEMODYNAMICS; HYPOTENSION; LIVER CIRCULATION; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; TIME; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; BLOOD VOLUME; CARDIAC OUTPUT; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; FLUID THERAPY; HEART RATE; HEMODYNAMICS; HYDRAZONES; HYPOTENSION; LACTIC ACID; LIPOPOLYSACCHARIDES; LIVER CIRCULATION; OXYGEN; PYRIDAZINES; REGIONAL BLOOD FLOW; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; SWINE; TIME FACTORS; VASCULAR RESISTANCE;

EID: 70350741538     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181af3fe3     Document Type: Article

References (27)

1. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994;271:226-233
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377
3. Silverman HJ, Penaranda R, Orens JB, Lee NH. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993;21: 31-39
4. Tavernier B, Garrigue D, Boulle C, Vallet B, Adnet P. Myofilament calcium sensitivity is decreased in skinned cardiac fibres of endotoxin-treated rabbits. Cardiovasc Res 1998;38:472-479
5. Yasuda S, Lew WY. Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myofilament response to Ca2- in cardiac myocytes. Circ Res 1997;81:1011-1020
6. Gelman S, Mushlin PS. Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics. Anesthesiology 2004;100:434-439
7. Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M. Effects of levosimendan, a novel inotropic calciumsensitizing drug, in experimental septic shock. Crit Care Med 2001;29:2185-2193
8. Dubin A, Murias G, Sottile JP, Pozo MO, Baran M, Edul VS, Canales HS, Etcheverry G, Maskin B, Estenssoro E. Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 2007;33:485-494
9. Matejovic M, Krouzecky A, Radej J, Novak I. Successful reversal of resistent hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 2005;49:127-128
10. Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005;31:638-644
11. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden IB. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995;27: 1859-1866
12. Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. Levosimendan, a novel Ca2- sensitizer, activates the glibenclamidesensitive K- channel in rat arterial myocytes. Eur J Pharmacol 1997;333:249-259
13. Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 2006;8:105-110
14. Cunha-Goncalves D, Perez-de-Sa V, Dahm P, Grins E, Thorne J, Blomquist S. Cardiovascular effects of levosimendan in the early stages of endotoxemia. Shock 2007;28:71-77
15. Martoft L, Jensen EW, Rodriguez BE, Jorgensen PF, Forslid A, Pedersen HD. Middle-latency auditory evoked potentials during induction of thiopentone anaesthesia in pigs. Lab Anim 2001;35:353-363
16. Tenhunen JJ, Uusaro A, Karja V, Oksala N, Jakob SM, Ruokonen E. Apparent heterogeneity of regional blood flow and metabolic changes within splanchnic tissues during experimental endotoxin shock. Anesth Analg 2003;97:555-563
17. Jakob SM, Tenhunen JJ, Laitinen S, Heino A, Alhava E, Takala J. Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs. Am J Physiol Gastrointest Liver Physiol 2001;280:G819-27
18. Shepherd AP, Riedel GL, Maxwell LC, Kiel JW. Selective vasodilators redistribute intestinal blood flow and depress oxygen uptake. Am J Physiol 1984;247:G377-84
19. Ali SZ, Bracht H, Krejci V, Beck M, Stalder M, Hiltebrand L, Takala J, Brandt S, Jakob SM. The immediate and sustained effects of volume challenge on regional blood flows in pigs. Anesth Analg 2008;106:595-600
20. Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology 2007;106:1156-1167
21. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K- channel in the mitochondrial inner membrane. Nature 1991;352:244-247
22. Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2- sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 1995;77:107-113
23. Leather HA, Ver Eycken K, Segers P, Herijgers P, Vandermeersch E, Wouters PF. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med 2003;31:2339-2343
24. Takasaki K, Tang LC, Urabe M. The beta-adrenergic responses in isolated splenic capsule area of several species of animals. Jpn J Pharmacol 1979;29:1-7
25. Swindle MM, Smith AC, Hepburn BJ. Swine as models in experimental surgery. J Invest Surg 1988;1:65-79
26. Brix-Christensen V, Andersen SK, Andersen R, Mengel A, Dyhr T, Andersen NT, Larsson A, Schmitz O, Orskov H, Tonnesen E. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology 2004;100:861-870
27. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004; 32:S451-4 (Pubitemid 39489020)